Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does IPILIMUMAB Cause Acute hepatic failure? 48 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 48 reports of Acute hepatic failure have been filed in association with IPILIMUMAB (YERVOY). This represents 0.1% of all adverse event reports for IPILIMUMAB.

48
Reports of Acute hepatic failure with IPILIMUMAB
0.1%
of all IPILIMUMAB reports
35
Deaths
38
Hospitalizations

How Dangerous Is Acute hepatic failure From IPILIMUMAB?

Of the 48 reports, 35 (72.9%) resulted in death, 38 (79.2%) required hospitalization, and 20 (41.7%) were considered life-threatening.

Is Acute hepatic failure Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for IPILIMUMAB. However, 48 reports have been filed with the FAERS database.

What Other Side Effects Does IPILIMUMAB Cause?

Death (3,710) Malignant neoplasm progression (3,296) Diarrhoea (2,557) Off label use (2,097) Colitis (1,988) Pyrexia (1,796) Rash (1,556) Fatigue (1,447) Intentional product use issue (1,329) Nausea (1,169)

What Other Drugs Cause Acute hepatic failure?

ACETAMINOPHEN (3,141) PREDNISONE (439) IBUPROFEN (412) RITUXIMAB (412) CYCLOPHOSPHAMIDE (411) DOXORUBICIN (385) VINCRISTINE (346) PREDNISOLONE (301) METHOTREXATE (285) DEXAMETHASONE (249)

Which IPILIMUMAB Alternatives Have Lower Acute hepatic failure Risk?

IPILIMUMAB vs IPRAGLIFLOZIN L-PROLINE IPILIMUMAB vs IPRATROPIUM IPILIMUMAB vs IPRATROPIUM\IPRATROPIUM ANHYDROUS IPILIMUMAB vs IPTACOPAN IPILIMUMAB vs IRBESARTAN

Related Pages

IPILIMUMAB Full Profile All Acute hepatic failure Reports All Drugs Causing Acute hepatic failure IPILIMUMAB Demographics